29.03.2019 - 1st Symposium on Optimised Cancer Treatments with 3D Models
The symposium was a complete success.
News
11.03.2019 - Mini-Symposium: Optimised Cancer Treatments with 3D Models
Visit the symposium in Munich on 27 March 2019.
27.02.2019 - abc biopply and BioConcept: a strong partnership for the Swiss market
abc biopply is looking forward to working together with BioConcept on the success of 3D CoSeedis™.
01.02.2019 - abc biopply at the Centre Léon Bérard in Lyon, France
Visit us on 5 February 2019 in France and learn more about 3D CoSeedis™.
09.01.2019 - Extracellular Vesicles Composition Affected by 3D Cell Architecture
3D CoSeedis™ has recently been used in a study on extracellular vesicle composition.
07.01.2019 - abc biopply goes international
3D CoSeedis™ is now available in Germany, Austria, France and Canada.
07.12.2018 - 3D CoSeedis™: valuable 3D data in radiation therapy response
A new publication about 3D CoSeedis™ is available.
26.11.2018 - Partnership with AnaPath
abc biopply has developed a standardised way to conveniently embed 3D cell aggregates grown in the 3D CoSeedis™ matrix in paraffin for immunological analysis. In this context we haverecently also started a partnership with AnaPath.
22.10.2018 - Introduction 3D CoSeedis™ Micro-Tumour System – WiDr
abc biopply is introducing a fully standardised 3D micro-tumour system based on its 3D CoSeedis™ technology platform.
13 June 2018 - New Micro-organoid Histology System
abc biopply launches a new 3D CoSeedis™ system in June.
29 May 2018 - abc biopply will attend the DECHEMA 3D Cell Culture Congress
Visit us at our booth E2 at the DECHEMA 3D Cell Culture Congress in Freiburg (DE)
17 May 2018 - 3D CoSeedis™ Webinar - Biostandardisation: Fast track for cancer diagnostics
Learn more about 3D CoSeedis™ and ask the experts directly.
April 2018 - Pressrelease about abc biopply
We have received attention in various newspapers.